Archive - Where Tech Meets Bio

February 2025

Weekly Tech+Bio Highlights #30: Roche’s Comeback to Sequencing

Also: AI and Pharmacovigilance, Advances in Aging Research, and more...

Feb 27 •

and

Weekly Tech+Bio Highlights #29

Also: This Company Suggests Six Criteria for Assessing AI’s Role in Drug Discovery, Modernizing Clinical Trials, AI-Designed Enzymes, New Ultrafast…

Feb 19 •

and

Weekly Tech+Bio Highlights #28

Also: On Combination Therapies in Oncology, Alzheimer’s Prevention Antibody Trial, and more...

Feb 12 •

and

Weekly Tech+Bio Highlights #27

Also: From LinkedIn to Drug Discovery; RNA Biomarkers for Predicting Better Responders; Recursion Expands into Clinical Trials, and More...

Feb 4 •

and

January 2025

December 2024

Concluding 2024: Weekly Highlights #24

Legal Challenges of AI in Drug Discovery; Virtual Cells in Real Tissue; Disrupting In Vitro Fertilization Status Quo

Dec 30, 2024 •

and

Where Are We Now With AI-driven Drug Discovery?🎄

The new research article raises important questions to focus on in 2025...

Dec 27, 2024 •

and

Weekly Tech+Bio Highlights #23

ALSO: New EGFR-binding Proteins, Designing Novel IBD Treatment Using Gen-AI, Toward AI-Driven Digital Organism...

Dec 17, 2024 •

,

, and

The '4th Wave' of AI Drug Discovery is Here, According to This Report

I’ve come across a really well-put report on the evolving state of artificial intelligence (AI) in drug discovery in 2024 and beyond, authored by Chris…

Dec 12, 2024 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts